Literature DB >> 17450476

Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT.

G Studer1, U M Lütolf, M El-Bassiouni, V Rousson, C Glanzmann.   

Abstract

The UICC classification (TNM) represents the validated standard tool to describe tumor extent and includes prognostic information on the probability of disease control. The American Joint Committee on Cancer (AJCC) stage grouping is based on the evaluation of treatment and outcome. Gross tumor volume (GTV) might be more relevant than pure description (TNM) or stage grouping as prognostic factor for local control in head and neck cancer (HNC). Based on the observation of GTV-correlated outcome in our initial HNC patient cohort treated with IMRT, we tested the hypothesis that the GTV is the most reliable predictive tool in HNC outcome. A GTV based volumetric staging system (VS) was introduced, using two volumetric cut-off values (15 and 70 cm3). VS, TNM, and AJCC stages were assessed and correlated with outcome following primary radiation in 172 HNC patients. Analyses were based on Kaplan-Meier survival curves. VS proved to be superior to the TNM/AJCC in predicting outcome. In addition, VS enabled to stratify high- and low-risk patients in advanced TN stages. GTV represented the most important prognostic indicator in HNC treated with IMRT and is recommended to be considered for therapeutic decisions and estimation of outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17450476     DOI: 10.1080/02841860600815407

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  34 in total

1.  Simultaneous integrated boost intensity-modulated radiotherapy (SIB‑IMRT) in nasopharyngeal cancer.

Authors:  Evangelia Peponi; Christoph Glanzmann; Guntram Kunz; Christoph Renner; Katja Tomuschat; Gabriela Studer
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

2.  Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy.

Authors:  Chia-Hung Kao; Shih-Chieh Lin; Te-Chun Hsieh; Kuo-Yang Yen; Shih-Neng Yang; Yao-Ching Wang; Ji-An Liang; Chun-Hung Hua; Shang-Wen Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-25       Impact factor: 9.236

3.  Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes.

Authors:  Benjamin H Lok; Jeremy Setton; Nicola Caria; Jonathan Romanyshyn; Suzanne L Wolden; Michael J Zelefsky; Jeffery Park; Nicholas Rowan; Eric J Sherman; Matthew G Fury; Alan Ho; David G Pfister; Richard J Wong; Jatin P Shah; Dennis H Kraus; Zhigang Zhang; Karen D Schupak; Daphna Y Gelblum; Shyam D Rao; Nancy Y Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-02       Impact factor: 7.038

4.  The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positron emission tomography scan.

Authors:  Paul B Romesser; Remy Lim; Daniel E Spratt; Jeremy Setton; Nadeem Riaz; Benjamin Lok; Shyam Rao; Eric J Sherman; Heiko Schöder; Nancy Y Lee
Journal:  Oral Oncol       Date:  2014-07-17       Impact factor: 5.337

5.  Predicting oropharyngeal tumor volume throughout the course of radiation therapy from pretreatment computed tomography data using general linear models.

Authors:  Adam D Yock; Arvind Rao; Lei Dong; Beth M Beadle; Adam S Garden; Rajat J Kudchadker; Laurence E Court
Journal:  Med Phys       Date:  2014-05       Impact factor: 4.071

6.  Predictive and prognostic factors for patients with locoregionally advanced laryngeal carcinoma treated with surgical multimodality protocol.

Authors:  Gorkem Eskiizmir; Gokce Tanyeri Toker; Onur Celik; Kivanc Gunhan; Ayca Tan; Hulya Ellidokuz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-10       Impact factor: 2.503

7.  Importance of tumor volume in supraglottic and glottic laryngeal carcinoma.

Authors:  L W van Bockel; E M Monninkhof; F A Pameijer; C H J Terhaard
Journal:  Strahlenther Onkol       Date:  2013-11-08       Impact factor: 3.621

8.  Prognostic value of tumor volumetry data of routine imaging data in a head and neck cancer registry.

Authors:  Daniela Oemus; Johanna Inhestern; Harald Schmalenberg; Stefan Schultze-Mosgau; Hans-Joachim Mentzel; Orlando Guntinas-Lichius
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-06       Impact factor: 2.503

9.  A prognostic volumetric threshold of gross tumor volume in head and neck cancer patients treated with radiotherapy.

Authors:  Paul B Romesser; Muhammad M Qureshi; Rathan M Subramaniam; Osamu Sakai; Scharukh Jalisi; Minh T Truong
Journal:  Am J Clin Oncol       Date:  2014-04       Impact factor: 2.339

10.  Outcome in recurrent head neck cancer treated with salvage-IMRT.

Authors:  Gabriela Studer; Klaus W Graetz; Christoph Glanzmann
Journal:  Radiat Oncol       Date:  2008-12-17       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.